Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin–vascular endothelial growth factor pathway
- 1 August 2013
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 271 (1) , 20-29
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in miceOncogene, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- RETRACTED AND REPLACED: microRNA involvement in human cancerCarcinogenesis, 2012
- Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 miceToxicology Letters, 2012
- Reversal and Prevention of Arsenic-Induced Human Bronchial Epithelial Cell Malignant Transformation by microRNA-200bToxicological Sciences, 2011
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- A Mechanism for Incorporation of Galectin-3 into the Spliceosome through Its Association with U1 snRNPBiochemistry, 2009
- Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2Free Radical Biology and Medicine, 2008
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2Journal of Biological Chemistry, 2008